Yonhap Infomax NewsFeb 25
Daewoong Pharmaceutical has signed a global licensing deal for microneedle-based obesity patches, aiming to capture a share of the rapidly expanding $200 billion global obesity treatment market by 2030.
#YonhapInfomax #DaewoongPharmaceutical #ObesityTreatment #MicroneedlePatch #Semaglutide #GlobalMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106743
Daewoong Pharmaceutical Targets Global Market with ‘Obesity Patch’

Daewoong Pharmaceutical has signed a global licensing deal for microneedle-based obesity patches, aiming to capture a share of the rapidly expanding $200 billion global obesity treatment market by 2030.

Yonhap Infomax